Plain-English translation of NCT06920134 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study evaluates the ARC-IM Therapy, an implanted electrical stimulation system designed to help manage blood pressure problems in people with Parkinson's disease. The trial focuses specifically on orthostatic hypotension — a condition where blood pressure drops dangerously when you stand up, causing dizziness, fainting, or difficulty with daily activities. Researchers want to see whether this treatment is safe and whether it can improve these symptoms.
People with Parkinson's disease often struggle with sudden blood pressure drops when standing, which can be disabling and difficult to treat with medication alone. This trial exists to explore whether electrical stimulation applied through an implanted device offers a new way to manage this problem.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will undergo surgery to have the ARC-IM device implanted in your spine. After implantation, the device will deliver electrical stimulation to help regulate your blood pressure when you stand. The study team will monitor your safety and measure how well the treatment works through regular visits and testing. You will need to commit to attending all scheduled appointments and following the study procedures carefully.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
Switzerland